Drug Type Small molecule drug |
Synonyms |
Target |
Action antagonists |
Mechanism CB1 antagonists(Cannabinoid CB1 receptor antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC28H30Cl2N4O4 |
InChIKeyNWMIXPUVCZYYCM-UHFFFAOYSA-N |
CAS Registry2836313-21-2 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Obesity | Preclinical | Israel | 21 Apr 2025 |